论文部分内容阅读
目的:探讨弥可保加银杏达莫治疗糖尿病周围神经病变的临床效果。方法:选取66例2型糖尿病伴有周围神经病变的患者,随机分为观察组和对照组各33例,观察组采用弥可保联合银杏达莫治疗,对照组单纯采用弥可保。4周为1个疗程。比较两组患者治疗前后的症状、体征、正中神经、腓总神经运动神经传导速度(MNCV)和感觉神经传导速度(SNCV)的情况。结果:观察组的临床疗效优于对照组(P<0.05),观察组的神经传导速度治疗后较治疗前显著改善(P<0.05),对照组的神经传导速度治疗后较治疗前则明显改善(P<0.05)。结论:银杏达莫联合弥可保治疗糖尿病周围神经病变疗效满意,优于单纯应用弥可保的疗效,值得借鉴。
Objective: To investigate the clinical effect of Mi Kebao plus ginkgo biloba on diabetic peripheral neuropathy. Methods: Sixty-six patients with type 2 diabetes mellitus with peripheral neuropathy were selected and randomly divided into observation group and control group with 33 cases in each. The observation group was treated with Mi-Pak and gingko-damo, while the control group was treated with Mi-Bao. 4 weeks for a course of treatment. The symptoms, signs, median nerve, peroneal nerve motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) were compared between the two groups before and after treatment. Results: The clinical curative effect of the observation group was better than that of the control group (P <0.05). The nerve conduction velocity of the observation group was significantly improved after treatment (P <0.05), while the nerve conduction velocity of the control group was significantly improved after treatment (P <0.05). Conclusion: Ginkgo biloba combined with miconazole treatment of peripheral neuropathy in diabetic patients with satisfactory results, better than the simple effect of the application of methycobal is worth learning.